Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 191

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

In Vivo Generation of CAR T Cells Selectively in Human CD4+ Lymphocytes

Open access
Agarwal, Shiwani, Hanauer, Julia D.S., Frank, Annika M., Riechert, Vanessa, Thalheimer, Frederic B., Buchholz, Christian J. · 2020 · Molecular Therapy

Abstract

T cells modified with CD19-specific chimeric antigen receptors (CARs) result in significant clinical benefit for leukemia patients but constitute a challenge for manufacturing. We have recently demonstrated the in vivo generation of CD19-CAR T cells using the CD8-targeted lentiviral vector (CD8-LV). In this study, we investigated the in vivo generation of CD4 + CAR T cells using CD4-targeted LV (CD4-LV). Administration of CD4-LV into NSG mice transplanted with human peripheral blood mononuclear cells (PBMCs) led to 40%–60% of human CD4 + lymphocytes being CAR positive while CD8 + cells remained CAR negative. CAR + T cells displayed a T helper 1 (Th1)/Th2 phenotype, which was accompanied by CD19 + B cell elimination. Intravenous administration of CD4-LV into NSG mice reconstituted with human CD34 + cells induced CAR expression and B cell elimination within 2–3 weeks post-injection. Preclinical analysis in a tumor mouse model revealed that mice administered CD4-LV exhibited faster and superior tumor cell killing compared to mice injected with CD8-LV alone or as a mixture with CD4-LV. Further analysis suggests that CD4 + CAR + cells may outperform CD8 + CAR + cells, especially at a high burden of target antigen, mainly since CD8 cells are more prone to exhaustion. This first description of in vivo -generated CD4 + CAR T cells supports their importance for cellular therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ymthe.2020.05.005

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 191

Metadata

Authors
Agarwal, S., Hanauer, J. D. S., Frank, A. M., Riechert, V., Thalheimer, F. B., & Buchholz, C. J.
Venue
Molecular Therapy
Publisher
Elsevier BV
Published
2020-08
Volume
28
Issue
8
Pages
1783-1794
ISSN
1525-0016 (ISSN-L)
OpenAlex
W3026009801
Cited by
191
References
4
FWCI
6.74
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: In Vivo Generation of CAR T Cells Selectively in Human CD4+ Lymphocytes. https://app.cochat.ai/papers/10.1016/j.ymthe.2020.05.005
The paper
Agarwal, S., Hanauer, J. D. S., Frank, A. M., Riechert, V., Thalheimer, F. B., & Buchholz, C. J. (2020). In Vivo Generation of CAR T Cells Selectively in Human CD4+ Lymphocytes. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2020.05.005

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.